Cargando…
Methylphenidate as a treatment option for substance use disorder: a transdiagnostic perspective
A transition in viewing mental disorders from conditions defined as a set of unique characteristics to one of the quantitative variations on a collection of dimensions allows overlap between disorders. The overlap can be utilized to extend to treatment approaches. Here, we consider the overlap betwe...
Autores principales: | van Ruitenbeek, Peter, Franzen, Luisa, Mason, Natasha Leigh, Stiers, Peter, Ramaekers, Johannes G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435872/ https://www.ncbi.nlm.nih.gov/pubmed/37599874 http://dx.doi.org/10.3389/fpsyt.2023.1208120 |
Ejemplares similares
-
Cannabis Use and Neuroadaptation: A Call for Δ(9)-Tetrahydrocannabinol Challenge Studies
por: Ramaekers, Johannes G., et al.
Publicado: (2022) -
Methylphenidate for Attention-Deficit and Hyperactivity Disorder in Adult Patients With Substance Use Disorders: Good Clinical Practice
por: Chamakalayil, Sunsha, et al.
Publicado: (2021) -
A Transdiagnostic Perspective on Social Anhedonia
por: Barkus, Emma, et al.
Publicado: (2019) -
A Transdiagnostic group therapy for sleep and anxiety among adults with substance use disorders: Protocol and pilot investigation
por: Milanak, Melissa E., et al.
Publicado: (2023) -
High reward expectancy during methylphenidate depresses the dopaminergic response to gain and loss
por: Evers, E.A., et al.
Publicado: (2016)